Immunomodulatory Effects of Fasting in Healthy Adults
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Nov 1, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of fasting on the immune system in healthy adults. Researchers want to see how a 36-hour period of drinking only water impacts the immune system, which helps our bodies fight off illnesses. They will look at blood samples and other measurements to understand these effects better.
To participate, you need to be a healthy male aged 20 to 40 years old, with a normal weight (between 120 lbs and a BMI of 19-27). You should also have stable blood sugar levels and be willing to fast for 36 hours. Participants will need to collect samples from their bowel movements for analysis and check their blood sugar levels during the fasting period. However, if you smoke, are pregnant, have certain health conditions, or take specific medications, you may not be eligible. This study is currently looking for volunteers, and your involvement could help scientists learn more about how fasting affects our health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 20-40 years, to constitute a young study population
- • Gender: male subjects, to control for gender differences
- • BMI: 19-27 kg/m2 to constitute a normal/healthy weight population
- • Weight: 120 lbs or more
- • Fasting glucose: 70-100 mg/dL, to ensure that fasting can be tolerated without inducing dangerously low levels of blood glucose
- • Subjects must be willing to undergo a period of 36 hours of water-only fasting
- • Subjects must be willing to collect samples of each bowel movement produced throughout the entire study period for microbiome analysis
- • Subjects must be willing to collect blood pricks for blood glucose levels using a Contour Next One Blood Glucose Testing Kit during the fasting stage of the study protocol.
- Exclusion Criteria:
- • Current smoking
- • Anemia
- • Pregnancy or current breastfeeding
- • Chronic diseases including diabetes mellitus, thyroid disease, metabolic syndrome, cancer, or previous cardiovascular events
- • Gastrointestinal diseases including irritable bowel syndrome, Crohn's disease, ulcerative colitis, celiac disease
- • Consumption of \>1 alcoholic drink/day
- • Extreme dietary or exercise patterns
- • Recent weight fluctuations (greater than 10% in the last six months)
- • Regular use of over-the-counter allergy or pain medications (\>1/week)
- • Taking prescription lipid medications (e.g. statins) or other supplements known to alter lipoprotein metabolism such as isoflavones
- • Use of hormonal birth control including oral contraception pills, hormonal IUDs or rings, or hormonal birth control patches
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials